Their ability to curb hunger makes them particularly effective for obesity management , explaining their rising popularity in weight loss treatments
Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats
It is now widely accepted that liraglutide therapy effectively promotes weight loss in obese individuals with/without T2D by reducing food intake via direct action on neurons in the brain
If you're currently on a prescription GLP-1 injection and you're thinking about switching, please speak to your healthcare provider first
J Physiol 535(Pt 1):301311 Simonson M, Boirie Y, Guillet C (2020) Protein, amino acids and obesity treatment
This effect is primarily mediated by two incretin hormones, namely glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)